Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) Japanese Gastric Cancer Association Special Article Open access 07 November 2022 Pages: 1 - 25
SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib Yan ChenRui ZhangSanjun Shi Original Article 24 August 2022 Pages: 26 - 43
Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type Kazushi FukagawaYu TakahashiMitsuhiro Fujishiro Original Article 12 September 2022 Pages: 44 - 54
Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells Luai Al-MarzoukiVivian S. StavrakosVeena Sangwan Original Article 04 September 2022 Pages: 55 - 68
Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis Yushuai MiQuanhui LiYinlu Ding Original Article Open access 16 September 2022 Pages: 69 - 81
IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC Jee Hyun KangSuyoung ParkHyo-Jung Kwon Original Article Open access 20 September 2022 Pages: 82 - 94
Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses Masayuki UrabeKeisuke MatsusakaAtsushi Kaneda Original Article 12 October 2022 Pages: 95 - 107
A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer Mitsuro KandaMasanori TerashimaYasuhiro Kodera Original Article 11 November 2022 Pages: 108 - 115
Cooperation between artificial intelligence and endoscopists for diagnosing invasion depth of early gastric cancer Atsushi GotoNaoto KubotaTaro Takami Original Article Open access 30 August 2022 Pages: 116 - 122
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial Josep TaberneroPaulo M. HoffYoon-Koo Kang Original Article Open access 06 September 2022 Pages: 123 - 131
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan Masahiko AokiShigenori KadowakiNarikazu Boku Original Article Open access 01 November 2022 Pages: 132 - 144
A continuous muscle-sparing advantage of pylorus-preserving gastrectomy for older patients with cT1N0M0 gastric cancer in the middle third of the stomach Masayoshi TerayamaManabu OhashiSouya Nunobe Original Article 07 October 2022 Pages: 145 - 154
Feasibility and safety of inserting transient biodegradable stents in the pylorus during pylorus-preserving gastrectomy for gastric cancer: a preliminary study in a porcine for proof of concept Ji-Hyeon ParkHyesung YoonHan-Kwang Yang Original Article 22 November 2022 Pages: 155 - 166
Correction to: Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences Alison RowsellSamantha C. SodergrenMitsumi Terada Correction Open access 21 October 2022 Pages: 167 - 167